ABT Total Non-Current Liabilities

Abbott Laboratories · Total Non-Current Liabilities

ABT logo

ABT Total Non-Current Liabilities

Latest reported$39.64B
ABT Quarterly Total Non-Current Liabilities ($809.20M → $39.64B)
High-resolution chart · PNG

ABT total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
39,639,000,000
39,351,000,000
17,446,000,000
18,335,000,000
19,731,000,000
19,380,000,000
19,356,000,000
19,426,000,000
19,697,000,000
19,403,000,000
20,546,000,000
21,354,000,000
21,600,000,000
22,032,000,000
22,044,000,000
23,552,000,000
25,094,000,000
25,731,000,000
26,067,000,000
26,290,000,000
26,626,000,000
26,535,000,000
27,638,000,000
27,191,000,000
27,019,000,000
25,542,000,000
25,723,000,000
26,029,000,000
27,471,000,000
27,368,000,000
27,439,000,000
27,963,000,000
28,690,000,000
30,297,000,000
36,240,000,000
32,095,000,000
32,560,000,000
32,694,000,000
27,634,000,000
10,280,000,000
10,363,000,000
10,402,000,000
10,735,000,000
11,751,000,000
11,814,000,000
11,901,000,000
9,104,000,000
8,698,000,000
7,918,000,000
7,987,000,000
8,179,000,000
9,012,881,000
9,556,086,000
9,597,012,000
27,141,536,000
19,867,419,000
20,166,838,000
20,086,444,000
20,270,520,000
19,525,243,000
19,694,610,000
19,705,928,000
19,723,368,000
20,307,025,000
18,697,508,000
17,162,797,000
16,468,405,000
15,947,563,000
15,667,568,000
15,684,186,000
13,347,745,000
12,847,738,000
13,098,367,000
12,427,583,000
12,832,106,000
9,730,690,000
9,808,852,000
9,661,870,000
10,172,791,000
10,232,470,000
11,181,577,000
6,928,815,000
7,310,418,000
5,809,413,000
7,352,271,000
7,311,688,000
7,616,067,000
7,313,425,000
7,236,292,000
7,587,320,000
6,003,549,000
6,250,849,000
6,664,861,000
6,566,840,000
6,592,347,000
6,395,974,000
6,296,006,000
6,367,903,000
6,310,174,000
6,266,573,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.